Diabetic Macular Edema, Clinicopathologic and Keys for Management

Ahmed Darwish

A chapter in Tertiary Care - Medical, Psychosocial, and Environmental Aspects from IntechOpen

Abstract: Diabetic retinopathy (DR) is one of the leading causes of blindness worldwide. It usually begins several years after the onset of diabetes. In the early stages, there are relatively mild retinal changes, the most important of which, regarding visual acuity (VA) affection, is diabetic macular edema (DME). Recently, the development of optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) greatly changed the treatment strategy of this part of diabetic retinopathy, particularly with the development of more advanced laser technologies as micropulse laser and more effective and longer acting anti-VEGF and steroid intravitreal medications and the advances in pars plana vitrectomy (PPV) techniques. In this chapter, all those points will be highlighted with how to prevent the progression of retinopathy to save as much as could be saved of the visual function.

Keywords: diabetes; macular edema; OCT; anti-VEGF; laser; steroids (search for similar items in EconPapers)
JEL-codes: I11 (search for similar items in EconPapers)
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.intechopen.com/chapters/88222 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ito:pchaps:320898

DOI: 10.5772/intechopen.112974

Access Statistics for this chapter

More chapters in Chapters from IntechOpen
Bibliographic data for series maintained by Slobodan Momcilovic (ai@intechopen.com).